Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-002679-25Phase 4Completed
Phase 4, open-label trial of bisacodyl in functional bowel disorder (FBD), irritable bowel syndrome (IBS), chronic constipation and 1 more (2 arms), sponsored by KU Leuven. Started Jul 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-002679-25.